Presentations highlight momentum of Pfizer's portfolio of infectious disease prevention and treatment options NEW YORK, October 8, 2024 - Pfizer Inc ...
Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...
Results that may be inaccessible to you are currently showing.